Cafepharma Today

January 3 2025 - Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Lilly asks to join GLP-1 compounding lawsuit
Use of diabetes and anti-obesity drugs surges nationwide
How pharma was instrumental in President Jimmy Carter’s global health efforts
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Salix Pharmaceuticals (SLXP) Presents Data on Mesalamine Granules Once-Daily Maintained Remission at ACG 2008
Street Insider
Tuesday, October 7, 2008 - 8:40am
tags:
Eli Lilly resolves investigation over Zyprexa with 32 states
Marketwatch
Tuesday, October 7, 2008 - 8:39am
tags:
AtheroGenics Files for Chapter 11 Bankruptcy
Yahoo
Tuesday, October 7, 2008 - 8:22am
tags:
Alpharma agrees to share confidential financials with suitor King Pharmaceuticals
Yahoo/AP
Tuesday, October 7, 2008 - 8:21am
tags:
Medicine for a sector
FT.com
Tuesday, October 7, 2008 - 7:53am
tags:
Medtronic CEO Hawkins Says Stent Patent Win Worth $114 Million
Bloomberg
Tuesday, October 7, 2008 - 7:52am
tags:
UBS Helps Lilly Buy ImClone, Says Price Too High
Bloomberg
Tuesday, October 7, 2008 - 7:50am
tags:
Genentech and Biogen say Rituxan slowed leukemia progress in late stage clinical trial
Yahoo/AP
Tuesday, October 7, 2008 - 7:49am
tags:
Four Thoughts on the Imclone/Lilly Deal
Seeking Alpha
Tuesday, October 7, 2008 - 7:46am
tags:
A Biotech Bonanza for ImClone and Dendreon
Seeking Alpha
Tuesday, October 7, 2008 - 7:45am
tags:
Synavive data sends CombinatoRx to all-time lows
Yahoo/AP
Tuesday, October 7, 2008 - 7:44am
tags:
Fitch may downgrade Eli Lilly's 'AA' on ImClone buy
Marketwatch
Tuesday, October 7, 2008 - 7:43am
tags:
Dendreon Misses, Moves Up
Forbes
Monday, October 6, 2008 - 10:58am
tags:
September FDA news in review
Fierce Pharma
Monday, October 6, 2008 - 10:57am
tags:
Icahn Wins, But Bristol Isn't A Total Loser Either
Forbes
Monday, October 6, 2008 - 10:56am
tags:
Dr. Reddy's Falls After Report on Diabetes Drug Delay
Bloomberg
Monday, October 6, 2008 - 10:27am
tags:
Genentech and OSI say Avastin and Tarceva miss main goal in late-stage clinical trial
Yahoo/AP
Monday, October 6, 2008 - 9:31am
tags:
BioSante Pharma Reaquires Elestrin
Seeking Alpha
Monday, October 6, 2008 - 9:31am
tags:
Discovery Labs: The Next Biotech Buy?
Seeking Alpha
Monday, October 6, 2008 - 9:30am
tags:
[video]Lilly/ImClone Deal
CNBC
Monday, October 6, 2008 - 9:29am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipes Blogging: Kebab-e-Koobideh
In the Pipeline
Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline

Latest Jobs

Vascular Consultant - 1719
League City, Texas, United States
FloodGate Medical
Clinical Specialist - $120K-$130K - Cardiovascular Space (Richmond, Charlottesville, Roanoke)
Roanoke, Virginia, United States
The Hoffman Group - Executive Recruiters
Associate Med device sales rep - diabetes
White Plains, New York, United States
DAVID BAGGA COMPANY
Specialty Account Manager - IVIG
Boston, Massachusetts, United States
CSI Pharmacy
Sales Representative, Iron Specialist, Women's Health - San Bernardino, CA
San Bernardino County, California, United States
RxSalesPros
Account Executive- Columbus
Columbus, Ohio, United States
CCS
Sales Representative, Iron Specialist, Women's Health - Sacramento, CA
Sacramento, California, United States
RxSalesPros
Territory Manager/ Pharmaceutical Sales Representative – Women’s Healthcare
Katy, Texas, United States
ImpactBio
Specialty Account Manager - IVIG
Charlotte, North Carolina, United States
CSI Pharmacy
Ophthalmology Pharmaceutical Sales Representative - Austin North Territory
Austin, Texas, United States
EVERSANA
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information